UNICREDIT BANK/PUT/BIOGEN IDEC/200/0.1/18.12.24 Share Price

Warrant

DE000HD0NWR8

Real-time BOERSE MUENCHEN 07:01:47 25/06/2024 BST
0.87 EUR 0.00% Intraday chart for UNICREDIT BANK/PUT/BIOGEN IDEC/200/0.1/18.12.24
Current month-12.12%
1 month-25.00%
Date Price Change
25/06/24 0.87 0.00%
24/06/24 0.87 -8.42%
21/06/24 0.95 +4.40%
20/06/24 0.91 -4.21%
19/06/24 0.95 0.00%

Real-time BOERSE MUENCHEN

Last update June 25, 2024 at 07:01 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying BIOGEN INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HD0NWR
ISINDE000HD0NWR8
Date issued 13/11/2023
Strike 200 $
Maturity 18/12/2024 (177 Days)
Parity 10 : 1
Emission price 1.71
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.35
Lowest since issue 0.78
Delta-0.24x
Omega 5.763
Premium15.86x
Gearing24.26x
Moneyness 0.8826
Difference Strike -26.6 $
Difference Strike %-13.30%
Spread 0.02
Spread %2.27%
Theoretical value 0.8701
Implied Volatility 37.12 %
Total Loss Probability 67.58 %
Intrinsic value 0.000000
Present value 0.8700
Break even 190.66 €
Theta-0.03x
Vega0.05x
Rho-0.03x

Company Profile

Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (17,2%) ; - other (9,1%): primarily revenues from partnership agreements.
Sector
-
More about the company

Ratings for Biogen Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Biogen Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
226.6 USD
Average target price
284.6 USD
Spread / Average Target
+25.61%
Consensus